Literature DB >> 17373588

The use of cytokeratin stain to distinguish Barrett's esophagus from contiguous tissues: a systematic review.

Zhannat Nurgalieva1, Angus Lowrey, Hashem B El-Serag.   

Abstract

Our objective was to systematically review the existing literature regarding the use of cytokeratin (CK) stain in differentiating Barrett's esophagus (BE) from tissues of the gastric cardia, corpus, or antrum, with or without intestinal metaplasia (IM). Pubmed was searched for full publications in English (1983-2005) addressing the use of CK for differentiation of BE from contiguous tissues. Information was collected on the study sample, blinding, the methods used for CK staining, and for defining and applying the gold standard tests. Test characteristics were obtained or calculated. Sixteen studies (containing 46 comparisons) met the inclusion and exclusion criteria. Immunostaining for CK 7 and 20 was generally highly specific in distinguishing long-segment BE from antrum IM, fundus IM, or noncardiac gastric IM; 27 comparisons showed statistically significant differences. However, only 8 of 15 comparisons (6 of 12 studies) reported significant differences in CK staining patterns between BE and gastric cardia IM with a high sensitivity (89%-100%) and specificity (83%-100%) for long-segment BE and lower estimates for short-segment BE, while the other seven comparisons showed no significant differences and a very low sensitivity. Examination by a blinded pathologist was reported in five of six positive studies and in only one of six of the negative studies. In addition, variation in the patient populations, use of surgical resection versus endoscopic biopsies, and biopsy sampling technique in endoscopic studies may have accounted for these differences. Finally, two studies did not find significant differences in CK staining patterns between BE and normal cardiac mucosa. In conclusions, CK immunostaining has not performed well in differentiating BE, especially short-segment BE, from cardia IM. There seems to be a spectrum bias where the accuracy varies with different tested populations. CK immunostaining distinguished well between BE and IM in noncardiac segments of the stomach; however, these comparisons are not clinically relevant.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17373588     DOI: 10.1007/s10620-006-9399-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  40 in total

1.  Cytokeratin 7/20 and MUC1, 2, 5AC, and 6 expression patterns in Barrett's esophagus and intestinal metaplasia of the stomach: intestinal metaplasia of the cardia is related to Barrett's esophagus.

Authors:  Christian Gulmann; Omar Al Shaqaqi; Antoinette Grace; Mary Leader; Stephen Patchett; David Butler; Elaine Kay
Journal:  Appl Immunohistochem Mol Morphol       Date:  2004-06

2.  Distribution of cytokeratin markers in Barrett's specialized columnar epithelium.

Authors:  J A Boch; H M Shields; D A Antonioli; F Zwas; R A Sawhney; J S Trier
Journal:  Gastroenterology       Date:  1997-03       Impact factor: 22.682

Review 3.  The significance and etiology of intestinal metaplasia of the esophagogastric junction.

Authors:  John R Goldblum
Journal:  Ann Diagn Pathol       Date:  2002-02       Impact factor: 2.090

Review 4.  Complex diseases in gastroenterology and hepatology: GERD, Barrett's, and esophageal adenocarcinoma.

Authors:  Rebecca C Fitzgerald
Journal:  Clin Gastroenterol Hepatol       Date:  2005-06       Impact factor: 11.382

5.  Barrett's Esophagus, a Complication of GERD.

Authors:  Richard E. Sampliner
Journal:  Curr Treat Options Gastroenterol       Date:  2002-02

6.  Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus.

Authors:  A H Ormsby; M F Vaezi; J E Richter; J R Goldblum; T W Rice; G W Falk; T L Gramlich
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

7.  Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI.

Authors:  J N Glickman; H Wang; K M Das; R K Goyal; S J Spechler; D Antonioli; R D Odze
Journal:  Am J Surg Pathol       Date:  2001-01       Impact factor: 6.394

8.  Cytokeratin immunoreactivity patterns in short-segment Barrett's esophagus in Japanese patients.

Authors:  Kazuyoshi Yagi; Atsuo Nakamura; Atsuo Sekine
Journal:  J Gastroenterol Hepatol       Date:  2005-06       Impact factor: 4.029

9.  Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction.

Authors:  I Jovanovic; M Tzardi; I A Mouzas; M Micev; P Pesko; T Milosavljevic; M Zois; M Sganzos; G Delides; P Kanavaros
Journal:  Histol Histopathol       Date:  2002-04       Impact factor: 2.303

10.  The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?

Authors:  Ozlem Kurtkaya-Yapicier; Rasim Gencosmanoglu; Erol Avsar; Nadi Bakirci; Nurdan Tozun; Aydin Sav
Journal:  BMC Clin Pathol       Date:  2003-12-02
View more
  9 in total

1.  Development and characterization of an organotypic model of Barrett's esophagus.

Authors:  Rachelle E Kosoff; Kristin L Gardiner; Lauren M F Merlo; Kirill Pavlov; Anil K Rustgi; Carlo C Maley
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

2.  Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study.

Authors:  Kee Wook Jung; Nicholas J Talley; Yvonne Romero; David A Katzka; Cathy D Schleck; Alan R Zinsmeister; Kelly T Dunagan; Lori S Lutzke; Tsung-Teh Wu; Kenneth K Wang; Mary Frederickson; Debra M Geno; G Richard Locke; Ganapathy A Prasad
Journal:  Am J Gastroenterol       Date:  2011-04-12       Impact factor: 10.864

Review 3.  Intermediate filament proteins of digestive organs: physiology and pathophysiology.

Authors:  M Bishr Omary
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-03-30       Impact factor: 4.052

4.  The dose of omeprazole required to achieve adequate intraesophageal acid suppression in patients with gastroesophageal junction specialized intestinal metaplasia and Barrett's esophagus.

Authors:  Joshua T Watson; Fouad J Moawad; Ganesh R Veerappan; John T Bassett; Corinne L Maydonovitch; John D Horwhat; Roy K H Wong
Journal:  Dig Dis Sci       Date:  2013-07-04       Impact factor: 3.199

5.  Gene expression in Barrett's esophagus: laser capture versus whole tissue.

Authors:  Hashem B El-Serag; Zhannat Z Nurgalieva; Toni-Ann Mistretta; Milton J Finegold; Rhonda Souza; Susan Hilsenbeck; Chad Shaw; Gretchen Darlington
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

Review 6.  Toward unraveling the complexity of simple epithelial keratins in human disease.

Authors:  M Bishr Omary; Nam-On Ku; Pavel Strnad; Shinichiro Hanada
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

7.  Diagnosing Barrett's esophagus: reliability of clinical and pathologic diagnoses.

Authors:  Douglas A Corley; Ai Kubo; Jolanda DeBoer; Gregory J Rumore
Journal:  Gastrointest Endosc       Date:  2009-01-18       Impact factor: 9.427

Review 8.  Histology of Barrett's Metaplasia: Do Goblet Cells Matter?

Authors:  Robert Odze
Journal:  Dig Dis Sci       Date:  2018-08       Impact factor: 3.199

9.  SOX15 governs transcription in human stratified epithelia and a subset of esophageal adenocarcinomas.

Authors:  Rita Sulahian; Justina Chen; Zoltan Arany; Unmesh Jadhav; Shouyong Peng; Anil K Rustgi; Adam J Bass; Amitabh Srivastava; Jason L Hornick; Ramesh A Shivdasani
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-11-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.